Clinical Trial Update: Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating methotrexate or thiotepa in combination with R-CHOP and orelabrutinib for central nervous system lymphoma; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Orelabrutinib (orelabrutinib)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• THIOTEPA (THIOTEPA)
• Vincristine (vincristine)

Snippet

Sponsor: Ruijin Hospital | Conditions: CNS Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING